Navigation Links
Verenium Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2010
Date:3/1/2011

on
  • SG&A: $23 to $25 million

  • Planned capital investments for the commercial business, including manufacturing debottlenecking, are expected to be between $4 and $6 million.  In addition, the Company expects to spend up to $10 million to build out a new San Diego, CA facility over the next two years and is exploring opportunities for spreading the capital expenditure over a longer period of time.

    About VereniumVerenium, an industrial biotechnology company, is a global leader in developing high-performance enzymes.  Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets.  Read more at www.verenium.com.

    Forward-Looking StatementsStatements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty.  These include, but are not limited to, statements related to Verenium's lines of business, operations, capabilities, commercialization activities, corporate partnerships, target markets and future financial performance, results and objectives, all of which are prospective.  Such statements are only predictions, and actual events or results may differ materially from those projected in such forward-looking statements.  Factors that could cause or contribute to the differences include, but are not limited to, risks associated with Verenium's strategic focus, risks associated with Verenium's technologies, risks associated with Verenium's ability to obtain additional capital to support its planned operations and financial obligations, risks associated with Verenium's dependence on patents and proprietary rights, risks associated with Verenium's protection and enforcement of its patents and proprietary rights, the commercial prospects of the industries in which Verenium operate
    '/>"/>

    SOURCE Verenium Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Verenium Announces 2010 Business Update and Outlook for 2011
    2. Verenium Announces Changes in Senior Management
    3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
    4. Spherix Reports Second Quarter Earnings
    5. Tapestry Reports Second Quarter 2007 Results
    6. Callisto Reports on Second-Quarter 2007 Milestones
    7. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
    8. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
    9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
    10. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
    11. Biopure Reports on Meeting with the FDA
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, ... and technologies must be able to protect ... (IP). (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ... nature of the Medical Device Industry, it ... industry sectors of cases involving IP infringement. ...
    (Date:1/15/2014)... , Jan. 15, 2014 The ... as a Medical Fitness Center by the Medical ... health and fitness centers to achieve their full ... the only certified fitness center in the western ... "The certification means the Cadence Fitness & ...
    (Date:1/15/2014)... 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Delivery Systems -- Focus on End Users ... STUDY OBJECTIVES A drug delivery ... aspects in today,s growth in the pharmaceutical ...
    Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
    (Date:4/16/2014)... 16, 2014 According to a new study, endoscopists, ... with one to two small polyps are consistent with ... may be an appropriate target for quality indicators. This ... adherence to guidelines for timing of repeat colonoscopy after ... colonoscopy in average-risk patients. The study appears in the ...
    (Date:4/15/2014)... Cases of diabetes and pre-diabetes in the United States ... the Johns Hopkins Bloomberg School of Public Health, with ... also found that the burden of the disease has ... diabetes in blacks, Hispanics and the elderly. , According ... issue of the Annals of Internal Medicine , ...
    (Date:4/15/2014)... Scientists have solved a decades-old medical mystery and ... to fight invasive fungal infections, which kill about 1.5 million ... mechanism of action of amphotericin, an antifungal drug that has ... though it is nearly as toxic to human cells as ... report of the new findings appears in Nature ...
    (Date:4/15/2014)... San Diego School of Medicine have identified a mechanism ... get liver disease and why the virus is able ... , The hard-to-kill pathogen, which infects an estimated 200 ... the mitochondria dismantling the cell,s innate ability ... mitochondrial dynamics. , The study, published in today,s issue ...
    (Date:4/14/2014)... in South Africa may provide insight on how to ... other areas of the world, which may have limited ... to successful interventions. , A report on the ... that due to the HIV/AIDS pandemic, which has left ... at an increased risk for mental health problems. ...
    Breaking Medicine News(10 mins):Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 2Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 3Health News:Pre-diabetes and diabetes nearly double over the past 2 decades 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 3Health News:Breaking bad mitochondria 2Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3
    ... 19 As they rush to save lives in the ... address myths about disaster relief among the American public. Edward ... five myths around disaster relief. , 1. Collecting blankets, shoes ... cost of shipping these items from around the country – let ...
    ... PORTLAND, Ore. , Jan. 18 To support ... Foundation donated $50,000 to Medical Teams International, a humanitarian ... provide medical assistance to areas throughout the world. The organization has ... , "It is difficult to comprehend the loss of life in ...
    ... Jan. 18 Tyco International (NYSE: TYC ) ... from continuing operations before special items for the first quarter of fiscal ... or $0.61 to $0.63 per share on a GAAP basis. This ... continuing operations before special items of $0.48 to $0.50 per ...
    ... from a cost model suggest that expenses for systemic ... rate than inflation, and newer biologically derived treatments are ... report in the January issue of Archives of ... is a chronic autoimmune disease that affects an estimated ...
    ... urge more doctors to ask simple question of male ... dysfunction is a strong warning sign that a man ... and other cardiovascular problems, a long-running study indicates. , ... Study] risk factors, men with erectile function still had ...
    ... suggest , MONDAY, Jan. 18 (HealthDay News) -- Appendicitis ... organ isn,t removed quickly, U.S. researchers say in a ... also theorize that viral infections can cause appendicitis. , ... is fast becoming history, thanks to new single-incision surgery ...
    Cached Medicine News:Health News:Myths of Disaster Relief 2Health News:Myths of Disaster Relief 3Health News:Regence Foundation Donates $50,000 to Aid Haiti Relief Efforts 2Health News:Tyco International Provides Update on First Quarter 2010 Performance 2Health News:Tyco International Provides Update on First Quarter 2010 Performance 3Health News:Tyco International Provides Update on First Quarter 2010 Performance 4Health News:Tyco International Provides Update on First Quarter 2010 Performance 5Health News:Costs of psoriasis treatments outpace inflation 2Health News:Erectile Dysfunction Predicts Heart Disease 2Health News:Study Questions Need for Emergency Appendectomies 2
    The Emit 2000 Digoxin Calibrators are intended for use with the Emit 2000 Digoxin Assay....
    ... The BD Macro-Vue RPR (Rapid Plasma ... Tear-drop Tests are nontreponemal testing procedures ... described in A Manual of Tests ... this manual are the most widely ...
    Agglutination test on slide for qualitative and quantitative determination of Syphilis in serum or plasma....
    ... quality assurance reagent in assays detecting IgG and ... TOXO IgM), IgG and IgM antibodies to rubella ... IgM antibodies to cytomegalovirus (CMV IgG and IgM), ... virus types 1 and 2 (HSV-1 IgG, HSV-1 ...
    Medicine Products: